EXHIBIT 99.1
SONTRA MEDICAL CORPORATION
(A Development Stage Company)
Consolidated Balance Sheet
As of September 30, 2003 | ||||
(Unaudited) | ||||
ASSETS: | ||||
Current Assets: | ||||
Cash and cash equivalents | $ | 2,800,434 | ||
Accounts receivable, net | 1,500,000 | |||
Prepaid expenses and other current assets | 97,047 | |||
Total current assets | 4,397,481 | |||
Property and Equipment, at cost | 746,480 | |||
Less-Accumulated depreciation and amortization | (460,624 | ) | ||
Net property and equipment | 285,856 | |||
Restricted Cash | 148,746 | |||
Other Assets | 74,972 | |||
Total assets | $ | 4,907,055 | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
Current Liabilities: | ||||
Accounts payable | $ | 287,828 | ||
Accrued expenses | 299,052 | |||
Total current liabilities | 586,880 | |||
Commitments | ||||
Stockholders’ Equity: | ||||
Common stock | 94,251 | |||
Additional paid-in capital | 18,109,456 | |||
Series A Convertible Preferred Stock | 3,223,958 | |||
Deferred stock-based compensation | (423,253 | ) | ||
Deficit accumulated during the development stage | (16,684,237 | ) | ||
Total stockholders’ equity | 4,320,175 | |||
Total liabilities and stockholders’ equity | $ | 4,907,055 | ||